Dr Edward R Flotte, MD | |
3280 Dauphin St, Building A, Mobile, AL 36606-4060 | |
(251) 450-3700 | |
(251) 662-3819 |
Full Name | Dr Edward R Flotte |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 26 Years |
Location | 3280 Dauphin St, Mobile, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780673814 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 26744 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Springhill Medical Center | Mobile, AL | Hospital |
Thomas Hospital | Fairhope, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Coastal Neurological Institute Pc | 4688617699 | 18 |
Imc-neurosurgery Llc | 7012267768 | 6 |
News Archive
Intralytix, Inc. announced today that its latest food safety product, SalmoFresh, has received GRAS (Generally Recognized As Safe) recognition from the Food and Drug Administration (FDA).
Biogen Idec announced today that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application (BLA) for ALPROLIX, the company's investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B.
During the 2008 Beijing Olympics, changes in air pollution were associated with changes in biomarkers of systemic inflammation and thrombosis (formation of blood clot) as well as measures of cardiovascular physiology in healthy young persons, according to a study in the May 16 issue of JAMA, a theme issue on Global Health.
Reader's Digest and the Alzheimer's Association partnered to survey approximately 1,600 people in May 2015 about their brain health and their knowledge of how lifestyle habits affect cognitive decline and dementia.
Infinity Pharmaceuticals, Inc. today provided guidance on its anticipated pipeline and business goals for 2011. Infinity begins the year with a broad pipeline of four drug candidates in clinical development and a fifth expected to enter the clinic during the year. The company also enters 2011 with approximately $345 million in committed capital.
› Verified 1 days ago
Entity Name | Coastal Neurological Institute Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740212174 PECOS PAC ID: 4688617699 Enrollment ID: O20050609000711 |
News Archive
Intralytix, Inc. announced today that its latest food safety product, SalmoFresh, has received GRAS (Generally Recognized As Safe) recognition from the Food and Drug Administration (FDA).
Biogen Idec announced today that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application (BLA) for ALPROLIX, the company's investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B.
During the 2008 Beijing Olympics, changes in air pollution were associated with changes in biomarkers of systemic inflammation and thrombosis (formation of blood clot) as well as measures of cardiovascular physiology in healthy young persons, according to a study in the May 16 issue of JAMA, a theme issue on Global Health.
Reader's Digest and the Alzheimer's Association partnered to survey approximately 1,600 people in May 2015 about their brain health and their knowledge of how lifestyle habits affect cognitive decline and dementia.
Infinity Pharmaceuticals, Inc. today provided guidance on its anticipated pipeline and business goals for 2011. Infinity begins the year with a broad pipeline of four drug candidates in clinical development and a fifth expected to enter the clinic during the year. The company also enters 2011 with approximately $345 million in committed capital.
› Verified 1 days ago
Entity Name | Imc-neurosurgery Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649778259 PECOS PAC ID: 7012267768 Enrollment ID: O20180830001777 |
News Archive
Intralytix, Inc. announced today that its latest food safety product, SalmoFresh, has received GRAS (Generally Recognized As Safe) recognition from the Food and Drug Administration (FDA).
Biogen Idec announced today that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application (BLA) for ALPROLIX, the company's investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B.
During the 2008 Beijing Olympics, changes in air pollution were associated with changes in biomarkers of systemic inflammation and thrombosis (formation of blood clot) as well as measures of cardiovascular physiology in healthy young persons, according to a study in the May 16 issue of JAMA, a theme issue on Global Health.
Reader's Digest and the Alzheimer's Association partnered to survey approximately 1,600 people in May 2015 about their brain health and their knowledge of how lifestyle habits affect cognitive decline and dementia.
Infinity Pharmaceuticals, Inc. today provided guidance on its anticipated pipeline and business goals for 2011. Infinity begins the year with a broad pipeline of four drug candidates in clinical development and a fifth expected to enter the clinic during the year. The company also enters 2011 with approximately $345 million in committed capital.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Edward R Flotte, MD 3280 Dauphin St, Building A, Mobile, AL 36606-4060 Ph: (251) 450-3700 | Dr Edward R Flotte, MD 3280 Dauphin St, Building A, Mobile, AL 36606-4060 Ph: (251) 450-3700 |
News Archive
Intralytix, Inc. announced today that its latest food safety product, SalmoFresh, has received GRAS (Generally Recognized As Safe) recognition from the Food and Drug Administration (FDA).
Biogen Idec announced today that the U.S. Food and Drug Administration has extended the initial Prescription Drug User Fee Act date for its review of the Biologics License Application (BLA) for ALPROLIX, the company's investigational long-lasting recombinant factor IX Fc fusion protein candidate for hemophilia B.
During the 2008 Beijing Olympics, changes in air pollution were associated with changes in biomarkers of systemic inflammation and thrombosis (formation of blood clot) as well as measures of cardiovascular physiology in healthy young persons, according to a study in the May 16 issue of JAMA, a theme issue on Global Health.
Reader's Digest and the Alzheimer's Association partnered to survey approximately 1,600 people in May 2015 about their brain health and their knowledge of how lifestyle habits affect cognitive decline and dementia.
Infinity Pharmaceuticals, Inc. today provided guidance on its anticipated pipeline and business goals for 2011. Infinity begins the year with a broad pipeline of four drug candidates in clinical development and a fifth expected to enter the clinic during the year. The company also enters 2011 with approximately $345 million in committed capital.
› Verified 1 days ago
Jeremy W Amps, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Suite D146, Mobile, AL 36608 Phone: 251-633-5155 Fax: 251-633-5125 | |
Dr. Donald R Tyler, M. D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3280 Dauphin St, Building A, Mobile, AL 36606 Phone: 251-450-3700 Fax: 251-662-3819 | |
Amber Shea Gordon, M.D. Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 3 Mobile Infirmary Cir Ste 410, Mobile, AL 36607 Phone: 251-435-6850 Fax: 251-435-6859 | |
Dr. Shawn B Clark, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd Ste D146, Mobile, AL 36608 Phone: 251-287-2176 Fax: 251-287-2279 | |
Dr. James Ronald Hirsch, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd Ste D146, Mobile, AL 36608 Phone: 251-287-2176 Fax: 251-287-2279 | |
Andrew Kessler Romeo, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Center St, Mobile, AL 36604 Phone: 251-660-5108 Fax: 251-660-5792 |